Since it is known that butyrate also acts as an HDAC inhibitor [53], here, we examined whether the butyrate treatment in the hSOD1G93A mice have an impact on CypD expression in skeletal muscle of the same ALS mouse model. Here, HDAC9 is linked to amyotrophic lateral sclerosis.